Mirum Pharmaceuticals raises target price to $195 from $140
MIRM•H.C. Wainwright raised its target price for Mirum Pharmaceuticals to $195 from $140.
Related News
Citi expands tokenized deposit service to Japan, UAE
C•
Sinclair’s KDNL rebrands as STL30 in St. Louis market
SBGI•
Nasdaq halts trading in XHLD for volatility at 12:19 p.m.
XHLD•
White House weighs red-dyed diesel tax relief to lower fuel prices
USO•
John Hancock Preferred Income Fund VP Investments Elisabeth Christino Stoll files initial beneficial ownership statement
HPI•